Dr. Thomas McCauley (UAB Physics PhD - Class of 1996) has assumed a Vice President position at Shire Pharmaceuticals. Dr. McCauley joined Shire in 2010 and heads its global nonclinical development.
In addition to his current focus on research and development of novel therapeutics for the Rare Disease, Neuroscience, Gastrointestinal, Internal Medicine and Regenerative Medicine business units, Tom has over thirteen years of experience in the biotechnology and pharmaceutical industries in preclinical and clinical discovery and development of biologic and small molecule drugs for indications in cardiovascular disease, hematology, oncology, inflammation and ophthalmology.
He holds undergraduate and graduate degrees from Cornell University, and received his PhD from the University of Alabama at Birmingham. Dr. McCauley's thesis work was in chemical vapor deposited diamond research. Previously Dr. McCauley worked at Brandies University and Argonne National Laboratory.
Physics Alumnus Thomas McCauley Heads Nonclinical Development Group at Shire Pharmaceuticals
Trailblazing Alumni
CAS News
April 19, 2015
More News
-
Researchers create a framework that could change the discovery of complex disease drug candidatesA team of UAB researchers have created an artificial intelligence framework that stands out among others of its kind. -
Putting AI First: Inside the strategy guiding UAB’s Department of Computer ScienceThe department has transformed its curriculum in response to AI, says chair Yuliang Zheng, Ph.D. This fall, it launches a renamed M.S. -
How to have a great family summer staycationUAB experts recommend activities to move children’s bodies or minds during the summer break.